Water extracts of cinnamon and clove exhibits potent inhibition of protein glycation and anti-atherosclerotic activity in vitro and in vivo hypolipidemic activity in zebrafish

Food and Chemical Toxicology

Volumn 49, Issue 7, 2011, Pages 1521-1529

  Jin, Seori ^a   Cho, Kyung Hyun ^a  

^a Yeungnam University   (South Korea)

Author keywords

Atherosclerosis; Cholesteryl ester transfer protein; Glycation; Herb and spice; Zebrafish

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; CINNAMON EXTRACT; CLOVE EXTRACT; COPPER; GINGER EXTRACT; LOW DENSITY LIPOPROTEIN; PEPPER EXTRACT; PLANT EXTRACT; ROSMARINUS OFFICINALIS EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIATHEROSCLEROTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BODY HEIGHT; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; HUMAN; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LIPID OXIDATION; MACROPHAGE FUNCTION; MALE; NONHUMAN; PHAGOCYTOSIS; PROTEIN GLYCOSYLATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ZEBRA FISH;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, LDL; CINNAMOMUM ZEYLANICUM; DISEASE MODELS, ANIMAL; EUGENIA; GINGER; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERCHOLESTEROLEMIA; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, HDL; MALE; PHAGOCYTOSIS; PLANT EXTRACTS; ROSMARINUS; ZEBRAFISH;

CINNAMOMUM VERUM; DANIO RERIO; ROSMARINUS OFFICINALIS; SYZYGIUM AROMATICUM; ZINGIBER OFFICINALE;

EID: 79957642319     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.03.043     Document Type: Article

References (40)

1. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.C., Krauss R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 1988, 260:1917-1921.
2. Babin P.J., Vernier J.M. Plasma lipoproteins in fish. J. Lipid Res. 1989, 30:467-489.
3. Bantle J.P. Dietary fructose and metabolic syndrome and diabetes. J. Nutr. 2009, 139:1263S-1268S.
4. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of " antioxidant power": the FRAP assay. Anal. Biochem. 1996, 239:70-76.
5. Blois M.S. Antioxidant determinations by the use of a stable free radical. Nature 1958, 181:1199-2000.
6. Brewer H.B., Ronan R., Meng M., Bishop C. Isolation and characterization of apolipoprotein A-I, A-II, and A-IV. Meth. Enzymol. 1986, 28:223-246.
7. Brousseau M.E. Emerging role of high-density lipoprotein in the prevention of cardiovascular disease. Drug Discov. Today 2005, 10:1095-1101.
8. Brown M.L., Inazu A., Hesler C.B., Agellon L.B., Mann C., Whitlock M.E., Marcel Y.L., Milne R.W., Koizumi J., Mabuchi H., Takeda R., Tall A.R. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989, 342:448-451.
9. Cho K.H. Synthesis of reconstituted high-density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL. Mol. Cells 2009, 27:291-297.
10. Cho K.H., Lee J.H., Kim J.M., Park S.H., Choi M.S., Lee Y.M., Choi I., Lee K.T. Blood lipid-lowering and antioxidant effects of a structured lipid containing monoacylglyceride enriched with monounsaturated fatty acids in C57BL/6 mice. J. Med. Food 2009, 12:452-460.
11. Craig W.J. Health-promoting properties of common herbs. Am. J. Clin. Nutr. 1999, 70:491S-499S.
12. Curtiss L.K., Witztum J.L. Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 1985, 34:452-461.
13. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free. Radic. Res. Commun. 1989, 6:67-75.
14. Gugliucci A. Glycation as the glucose link to diabetic complications. J. Am. Osteopath. Assoc. 2000, 100:621-634.
15. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
16. Hedrick C.C., Thorpe S.R., Fu M.X., Harper C.M., Yoo J., Kim S.M., Wong H., Peters A.L. Glycation impairs high-density lipoprotein function. Diabetologia 2000, 43:312-320.
17. Hoang A., Murphy A.J., Coughlan M.T., Thomas M.C., Forbes J.M., O'Brien R., Cooper M.E., Chin-Dusting J.P., Sviridov D. Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia 2007, 50:1770-1779.
18. Jassim S.A.A., Naji M.A. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 2003, 95:412-427.
19. Jin S., Hong J.H., Jung S.H., Cho K.H. Turmeric and laurel aqueous extracts exhibit in vitro anti-atherosclerotic activity and in vivo hypolipidemic effects in a zebrafish model. J. Med. Food 2011, 14:247-256.
20. Khan A., Safdar M., Ali Khan M.M., Khattak K.N., Anderson R.A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes care 2003, 26:3215-3218.
21. McPherson J.D., Shilton B.H., Walton D.J. Role of fructose in glycation and cross-linking of proteins. Biochemistry 1988, 27:1901-1907.
22. Modak M., Dixit P., Londhe J., Ghaskadbi S., Devasagayam T.P.A. Indian herbs and herbal drugs used for the treatment of diabetes. J. Clin. Biochem. Nutr. 2007, 40:163-173.
23. Monnier V.M., Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981, 211:491-493.
24. Noble R.P. Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 1968, 9:693-700.
25. Oya T., Osawa T., Kawakishi S. Spice constituents scavenging free radicals and inhibiting pentosidine formation in a model system. Biosci. Biotechnol. Biochem. 1997, 61:263-266.
26. Park K.H., Shin D.G., Kim J.R., Cho K.H. Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity. J. Gerontol. A. Biol. Sci. Med. Sci. 2010, 65:600-610.
27. Park, K.H., Cho, K.H. (in press). High-density lipoproteins (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share pro-atherosclerotic and pro-senescent properties with increased cholesterol influx. J. Gerontol. A. Biol. Sci. Med. Sci.
28. Peterson D.W., George R.C., Scaramozzino F., LaPointe N.E., Anderson R.A., Graves D.J., Lew J. Cinnamon extract inhibits Tau aggregation associated with Alzheimer's disease in vitro. J. Alzheimers Dis. 2009, 17:585-597.
29. Ravi K., Sivagnanam K., Subramanian S. Anti-diabetic activity of Eugenia jambolana Seed kernels on streptozotocin-induced diabetic rats. J. Med. Food 2004, 7:187-191.
30. Recalde D., Baroukh N., Viglietta C., Prince S., Verona J., Vergnes L., Pidoux J., Nanjee M.N., Brites F., Ochoa A., Castro G., Zakin M.M., Miller N.E., Houdebine L.M. Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet. FEBS Lett. 2004, 572:294-298.
31. Schaefer E.J., Asztalos B.F. Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reduction. Curr. Opin. Lipidol. 2006, 17:394-398.
32. Sharma B., Balomajumder C., Roy P. Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolama seeds on streptozotocin induced diabetic rats. Food Chem. Toxicol. 2008, 46:2376-2383.
33. Siddiqui Y.M., Ettayebi M., Haddad A., Al-Ahdal M.N. Effect of essential oils on enveloped viruses: antiviral activity of oregano and clove oils on herpes simplex virus type 1 and Newcastle disease virus. Med. Sci. Res. 1996, 24:185-186.
34. Stecchini M.L., Sarais L., Giavedoni P. Effect of essential oils on Aeromonas hydrophila in a culture medium and in cooked pork. J. Food Prot. 1993, 56:406-409.
35. Stoletov K., Fang L., Choi S.H., Hartvigsen K., Hansen L.F., Hall C., Pattison J., Juliano J., Miller E.R., Almazan F., Crosier P., Witztum J.L., Klemke R.L., Miller Y.I. Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ. Res. 2009, 104:952-960.
36. Sviridov D., Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 2002, 161:245-254.
37. Wei A., Shibamoto T. Antioxidant activities of essential oil mixtures toward skin lipid squalene oxidized by UV irradiation. Cutan. Ocul. Toxicol. 2007, 26:227-233.
38. Younis N., Charlton-Menys V., Sharma R., Soran H., Durrington P.N. Glycation of LDL in non-diabetic people: small dense LDL is preferentially glycated both in vivo and in vitro. Atherosclerosis 2009, 202:162-168.
39. Younis N., Sharma R., Soran H., Charlton-Menys V., Elseweidy M., Durrington P.N. Glycation as an atherogenic modification of LDL. Curr. Opin. Lipidol. 2008, 19:378-384.
40. Zheng G.Q., Kenney P.M., Lam L.K. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J. Nat. Prod. 1992, 55:999-1003.